Cargando…

Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I

AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantz, Stefan, Klaiber, Michael, Baba, Hideo A., Oberwinkler, Heike, Völker, Katharina, Gaβner, Birgit, Bayer, Barbara, Abeβer, Marco, Schuh, Kai, Feil, Robert, Hofmann, Franz, Kuhn, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631523/
https://www.ncbi.nlm.nih.gov/pubmed/22199120
http://dx.doi.org/10.1093/eurheartj/ehr445
_version_ 1782266792204304384
author Frantz, Stefan
Klaiber, Michael
Baba, Hideo A.
Oberwinkler, Heike
Völker, Katharina
Gaβner, Birgit
Bayer, Barbara
Abeβer, Marco
Schuh, Kai
Feil, Robert
Hofmann, Franz
Kuhn, Michaela
author_facet Frantz, Stefan
Klaiber, Michael
Baba, Hideo A.
Oberwinkler, Heike
Völker, Katharina
Gaβner, Birgit
Bayer, Barbara
Abeβer, Marco
Schuh, Kai
Feil, Robert
Hofmann, Franz
Kuhn, Michaela
author_sort Frantz, Stefan
collection PubMed
description AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown to counter-regulate pathological hypertrophy. It was suggested that cGMP-dependent protein kinase I (cGKI) mediates this protective effect, although the role in vivo is under debate. Here, we investigated whether cGKI modulates myocyte growth and/or function in the intact organism. METHODS AND RESULTS: To circumvent the systemic phenotype associated with germline ablation of cGKI, we inactivated the murine cGKI gene selectively in cardiomyocytes by Cre/loxP-mediated recombination. Mice with cardiomyocyte-restricted cGKI deletion exhibited unaltered cardiac morphology and function under resting conditions. Also, cardiac hypertrophic and contractile responses to β-adrenoreceptor stimulation by isoprenaline (at 40 mg/kg/day during 1 week) were unaltered. However, angiotensin II (Ang II, at 1000 ng/kg/min for 2 weeks) or transverse aortic constriction (for 3 weeks) provoked dilated cardiomyopathy with marked deterioration of cardiac function. This was accompanied by diminished expression of the [Ca(2+)](i)-regulating proteins SERCA2a and phospholamban (PLB) and a reduction in PLB phosphorylation at Ser(16), the specific target site for cGKI, resulting in altered myocyte Ca(2+)(i) homeostasis. In isolated adult myocytes, CNP, but not ANP, stimulated PLB phosphorylation, Ca(2+)(i)-handling, and contractility via cGKI. CONCLUSION: These results indicate that the loss of cGKI in cardiac myocytes compromises the hypertrophic program to pathological stimulation, rendering the heart more susceptible to dysfunction. In particular, cGKI mediates stimulatory effects of CNP on myocyte Ca(2+)(i) handling and contractility.
format Online
Article
Text
id pubmed-3631523
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-36315232013-04-22 Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I Frantz, Stefan Klaiber, Michael Baba, Hideo A. Oberwinkler, Heike Völker, Katharina Gaβner, Birgit Bayer, Barbara Abeβer, Marco Schuh, Kai Feil, Robert Hofmann, Franz Kuhn, Michaela Eur Heart J Basic Science AIMS: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown to counter-regulate pathological hypertrophy. It was suggested that cGMP-dependent protein kinase I (cGKI) mediates this protective effect, although the role in vivo is under debate. Here, we investigated whether cGKI modulates myocyte growth and/or function in the intact organism. METHODS AND RESULTS: To circumvent the systemic phenotype associated with germline ablation of cGKI, we inactivated the murine cGKI gene selectively in cardiomyocytes by Cre/loxP-mediated recombination. Mice with cardiomyocyte-restricted cGKI deletion exhibited unaltered cardiac morphology and function under resting conditions. Also, cardiac hypertrophic and contractile responses to β-adrenoreceptor stimulation by isoprenaline (at 40 mg/kg/day during 1 week) were unaltered. However, angiotensin II (Ang II, at 1000 ng/kg/min for 2 weeks) or transverse aortic constriction (for 3 weeks) provoked dilated cardiomyopathy with marked deterioration of cardiac function. This was accompanied by diminished expression of the [Ca(2+)](i)-regulating proteins SERCA2a and phospholamban (PLB) and a reduction in PLB phosphorylation at Ser(16), the specific target site for cGKI, resulting in altered myocyte Ca(2+)(i) homeostasis. In isolated adult myocytes, CNP, but not ANP, stimulated PLB phosphorylation, Ca(2+)(i)-handling, and contractility via cGKI. CONCLUSION: These results indicate that the loss of cGKI in cardiac myocytes compromises the hypertrophic program to pathological stimulation, rendering the heart more susceptible to dysfunction. In particular, cGKI mediates stimulatory effects of CNP on myocyte Ca(2+)(i) handling and contractility. Oxford University Press 2013-04-21 2011-12-23 /pmc/articles/PMC3631523/ /pubmed/22199120 http://dx.doi.org/10.1093/eurheartj/ehr445 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author [2011]. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic Science
Frantz, Stefan
Klaiber, Michael
Baba, Hideo A.
Oberwinkler, Heike
Völker, Katharina
Gaβner, Birgit
Bayer, Barbara
Abeβer, Marco
Schuh, Kai
Feil, Robert
Hofmann, Franz
Kuhn, Michaela
Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title_full Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title_fullStr Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title_full_unstemmed Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title_short Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
title_sort stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic gmp-dependent protein kinase i
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631523/
https://www.ncbi.nlm.nih.gov/pubmed/22199120
http://dx.doi.org/10.1093/eurheartj/ehr445
work_keys_str_mv AT frantzstefan stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT klaibermichael stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT babahideoa stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT oberwinklerheike stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT volkerkatharina stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT gabnerbirgit stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT bayerbarbara stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT abebermarco stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT schuhkai stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT feilrobert stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT hofmannfranz stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei
AT kuhnmichaela stressdependentdilatedcardiomyopathyinmicewithcardiomyocyterestrictedinactivationofcyclicgmpdependentproteinkinasei